Myocardial osteopontin expression is associated with left ventricular hypertrophy.
about
Osteopontin: At the cross-roads of myocyte survival and myocardial functionOsteopontin expression in coculture of differentiating rat fetal skeletal fibroblasts and myoblastsDifferential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI.Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney DiseaseA locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice.Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy.Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy.Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels.Potential Markers in Cardiac Hypertrophy?IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.Inhibition of osteopontin reduce the cardiac myofibrosis in dilated cardiomyopathy via focal adhesion kinase mediated signaling pathwayRole of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy.Mechanisms of intermittent hypoxia induced hypertension.Deep sequence analysis of gene expression identifies osteopontin as a downstream effector of integrin-linked kinase (ILK) in cardiac-specific ILK knockout miceRole of osteopontin in heart failure associated with aging.Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stress.Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction.Matricellular proteins: new molecular targets to prevent heart failure.Targeting osteopontin, the silent partner of Na+/H+ exchanger isoform 1 in cardiac remodeling.Effects of 6-months' Exercise on Cardiac Function, Structure and Metabolism in Female Hypertensive Rats-The Decisive Role of Lysyl Oxidase and Collagen III.Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.Molecular and Digital Biomarker Supported Decision Making in Clinical Studies in Cardiovascular Indications.Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy.Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy.Cardioprotective effects of osteopontin-1 during development of murine ischemic cardiomyopathy.Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI).Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy.Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression.Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species.Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension.Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.Deletion of the alpha8 integrin gene does not protect mice from myocardial fibrosis in DOCA hypertension.Osteopontin expression in normal and hypobaric hypoxia-exposed rats.Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse.Increased myocardial expression of osteopontin in patients with advanced heart failure.Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
P2860
Q28248833-71D4E7EA-BCFF-42E4-9DFF-54F4A035D3A3Q28583287-C7B66D3B-DB6E-456C-A5EF-A8A63B52F1B3Q30483132-F9643C46-14D1-4401-855A-3E724EADB2D7Q33664039-199472F6-9B53-44B3-9C1D-37BC1EF42CA1Q35072941-F7A307E9-5484-4245-9B99-26964521AEE0Q35097446-480D119F-0466-4F38-A9BA-D1CC555B2FE2Q35391254-B0B9EF3B-01D4-4CCC-8A4A-9513584993ABQ35788752-F505A201-6007-4F66-9C5C-8FB1A1858BC0Q37076096-0D64F0BD-E659-4079-8A8B-D1A254B6F913Q37086060-80B9E5BA-80DF-4A5E-8D45-99B8862ED760Q37155198-CC120BFA-F3AC-4D6F-A071-D1A08AFA0F7AQ37264496-754D66BB-25DF-40ED-AE0C-8BA6D768A0FEQ37293114-953ABFE0-169E-4043-A04D-114C64747551Q37467862-4137A9AA-042C-4925-9F2D-28C5DDF1ADF6Q37612046-38B025D9-0803-4039-BC82-CCB427182200Q37631255-997646E8-6EC4-4EEC-8D98-A7E3959A6BA4Q37686295-210EE98B-F4C6-47BC-B931-48BFE1ADD095Q37707655-6BEA3132-008E-47F0-9E3C-1F670E3CC7EBQ37871839-68B6FC52-9F86-4225-975E-E1FF3B9F2E6BQ37925022-188A54FC-A6EB-498E-82D2-760BE2C3ED77Q38354012-F158073B-C6F4-4DFA-B277-D059CD6D6981Q38616784-66178DDF-5C55-4469-BAB5-AE2405437A42Q38814473-07621CFD-41CA-464B-853F-4DCAADF573F2Q38815451-50FEEDBB-0DC9-49E0-B526-8EC34B190124Q39726169-FF8B4090-1D39-48FA-9CD5-E7787D13D91BQ39751376-464995F7-CE01-4A38-8FC4-5FF5FAE05D97Q40723450-A7811E62-4F29-44B7-A32C-5E41BC91B8E4Q41045920-8768622B-670F-4705-89BD-08C1773337F4Q42104854-D5C6A869-1C92-46B1-A3F5-7D3DBF578F7FQ42412748-BF7658E1-51DF-40CA-9477-26E85302C42DQ42505155-74FFA169-76D1-4CE9-A472-E5E59885F6FDQ43807471-17E93606-FEE4-486C-910E-8B71AC12B890Q44441993-4CCC0459-D635-4E9C-9F22-791F1B435213Q44657473-BB43085A-3A2D-4BF4-B7E5-3E21E5694B8EQ45716394-98AAC4EA-0E42-4D2C-996D-1E20741086F1Q46247002-2ABE45AC-014D-4DE2-9AD5-71862CD18E01Q47903815-D233984D-FC92-4007-A7EC-3A9A784406D6Q51212373-041AB5A7-5DCE-4175-B3CD-5BA06BB380B1Q52042603-B5519030-6C28-47B5-B097-1B459E858E08Q52656588-F33B45E5-2357-4898-AA27-2425BB46D24E
P2860
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@en
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@nl
type
label
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@en
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@nl
prefLabel
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@en
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@nl
P2093
P356
P1433
P1476
Myocardial osteopontin expression is associated with left ventricular hypertrophy.
@en
P2093
Ashizawa N
Giachelli CM
P304
P356
10.1161/01.CIR.96.9.3063
P407
P577
1997-11-01T00:00:00Z